Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains
- 1 March 2007
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 29 (3) , 263-270
- https://doi.org/10.1016/j.ijantimicag.2006.08.049
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Macrolide Antibiotics: A Pharmacokinetic and Pharmacodynamic OverviewCurrent Pharmaceutical Design, 2004
- PK–PD modelling of the effect of cefaclor on four different bacterial strainsInternational Journal of Antimicrobial Agents, 2004
- Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MICAntimicrobial Agents and Chemotherapy, 2004
- In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalisInternational Journal of Antimicrobial Agents, 2003
- Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrationsInternational Journal of Antimicrobial Agents, 2002
- Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 Compared to Their Susceptibilities to 11 Other AgentsAntimicrobial Agents and Chemotherapy, 2001
- A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans.Journal of Antimicrobial Chemotherapy, 2000
- A Time–Kill Evaluation of Clarithromycin and Azithromycin against Two Extracellular Pathogens and the Development of ResistanceAnnals of Pharmacotherapy, 1999
- Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusionAntimicrobial Agents and Chemotherapy, 1997
- Pharmacokinetic-Pharmacodynamic Modeling of the Antibiotic Effect of Piperacillin in VitroPharmaceutical Research, 1996